IRIS
BRACCI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.711
EU - Europa 12.486
AS - Asia 6.391
SA - Sud America 1.084
AF - Africa 356
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 11
Totale 36.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.512
GB - Regno Unito 2.828
RU - Federazione Russa 2.389
CN - Cina 2.386
SG - Singapore 1.838
IT - Italia 1.553
IE - Irlanda 1.501
SE - Svezia 956
BR - Brasile 885
UA - Ucraina 883
DE - Germania 835
FR - Francia 641
VN - Vietnam 603
HK - Hong Kong 468
KR - Corea 344
FI - Finlandia 328
ZA - Sudafrica 197
IN - India 179
ES - Italia 157
BD - Bangladesh 118
CA - Canada 113
PL - Polonia 90
BE - Belgio 75
NL - Olanda 68
AR - Argentina 66
JP - Giappone 63
TR - Turchia 57
PK - Pakistan 52
MX - Messico 48
NG - Nigeria 46
IQ - Iraq 39
CZ - Repubblica Ceca 34
EC - Ecuador 33
IR - Iran 28
AT - Austria 26
CI - Costa d'Avorio 25
VE - Venezuela 25
AU - Australia 23
ID - Indonesia 23
PH - Filippine 22
CL - Cile 19
KE - Kenya 19
CH - Svizzera 18
MA - Marocco 18
UZ - Uzbekistan 18
AE - Emirati Arabi Uniti 16
EG - Egitto 16
CO - Colombia 15
IL - Israele 15
LT - Lituania 15
SA - Arabia Saudita 15
AZ - Azerbaigian 14
RO - Romania 14
JO - Giordania 13
PE - Perù 13
PY - Paraguay 12
EU - Europa 11
KZ - Kazakistan 11
TN - Tunisia 11
DZ - Algeria 10
RS - Serbia 9
EE - Estonia 8
JM - Giamaica 8
KG - Kirghizistan 8
NP - Nepal 8
BG - Bulgaria 7
BO - Bolivia 7
BY - Bielorussia 7
DK - Danimarca 7
LB - Libano 7
AL - Albania 6
BB - Barbados 6
ET - Etiopia 6
MY - Malesia 6
PA - Panama 6
HU - Ungheria 5
NZ - Nuova Zelanda 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AM - Armenia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
LA - Repubblica Popolare Democratica del Laos 4
PT - Portogallo 4
CY - Cipro 3
GE - Georgia 3
GY - Guiana 3
HR - Croazia 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
GR - Grecia 2
HN - Honduras 2
LK - Sri Lanka 2
Totale 36.040
Salva come PNG Salva come JPEG
Città #
Southend 2.485
Dallas 1.810
Dublin 1.483
Fairfield 1.448
Ashburn 1.150
Singapore 1.014
Chandler 875
Menlo Park 839
Woodbridge 716
Jacksonville 715
Moscow 673
Santa Clara 629
Houston 577
Beijing 562
Seattle 552
San Jose 529
Wilmington 524
Siena 502
Ann Arbor 492
Cambridge 447
Hong Kong 445
Hefei 414
Seoul 341
Princeton 272
Los Angeles 232
The Dalles 228
New York 224
Nanjing 216
Johannesburg 183
Ho Chi Minh City 157
Council Bluffs 146
Munich 146
Helsinki 139
Lauterbourg 138
Boardman 129
Hanoi 125
Milan 123
Málaga 113
Shanghai 110
San Mateo 109
Buffalo 96
Florence 93
Dong Ket 91
Nanchang 89
São Paulo 88
San Diego 84
Rome 74
Fremont 62
Hebei 59
London 59
Shenyang 58
Warsaw 58
Brussels 56
Dearborn 53
Orem 51
Tianjin 49
Washington 48
Chicago 47
Abuja 46
Bengaluru 45
Frankfurt am Main 45
Turku 43
Tokyo 42
Brooklyn 41
Columbus 41
Redwood City 41
Toronto 41
Kunming 39
Chennai 37
Jiaxing 37
Jinan 33
Phoenix 32
Redondo Beach 31
Changsha 30
Montreal 30
Stockholm 30
Düsseldorf 29
Izmir 29
Amsterdam 27
Da Nang 27
Denver 26
Abidjan 25
Atlanta 25
Dhaka 25
Lancaster 25
Rio de Janeiro 25
University Park 25
Haiphong 24
Zhengzhou 24
Brno 23
Manchester 23
Brasília 22
Hangzhou 22
San Francisco 22
Bagno a Ripoli 21
Belo Horizonte 21
Lappeenranta 21
Poplar 21
Guangzhou 20
Nuremberg 20
Totale 24.483
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 376
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 369
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 368
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 364
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 364
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 359
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 356
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment 355
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 353
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 337
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 326
11β-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts 322
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 322
A model of the rabies virus glycoprotein active site 315
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 312
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 310
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist 308
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 308
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 305
A new NT4 peptide-based drug delivery system for cancer treatment 304
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 303
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 303
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 302
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 301
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 295
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 292
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 288
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 288
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 287
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 287
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 280
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 278
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 276
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 276
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 274
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 274
Tumor imaging with tetrabranched neurotensin 268
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 264
HIV-1 gp 120 binding to nicotinig receptors 264
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 264
Branched peptides as bioactive molecules for drug design 262
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 260
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 259
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 259
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 256
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 253
Branched peptides for tumor diagnosis and therapy 249
Antibacterial peptides and analogues thereof 249
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 249
Branched Neurotensin For Tumor Targeting 249
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 244
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 244
Bioactive peptides from libraries 243
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 243
An antigenic determinant common to human chorionic somatomammotropin and human growth hormone revealed by limited proteolysis of immune complexes 242
Nanoparticles exposing neurotensin tumor-specific drivers 241
Branched peptides as targeting agents for tumor imaging and therapy 240
HIV-1 and human myelin proteins share an antigenic determinant 239
Toxin-related antibodies with antimicrobial and antiviral activity 238
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 238
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 233
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 232
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 231
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 230
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 229
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 227
Endogenous morphine modulates acute thermonociception in mice 227
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 226
Branched Neurotensin peptides for tumor personalized therapy 226
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 225
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 224
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 224
Branched multimeric peptides for tumor diagnosis and therapy 221
Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein 220
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 220
Synthetic peptides in the form of dendrimers become resistant to protease activity 220
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 219
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 218
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 218
Identification of a neutralizing epitope on tosv gn glycoprotein 215
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 213
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 210
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 209
The antimicrobial peptide M33. An example of drug development 209
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate 208
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 208
The development of antimicrobial peptides as new antibacterial drugs 207
Branched neurotensin for tumor targeting 206
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 204
Determination of antigen-specific immunoglobulin content in ascitic fluids and antisera 202
Tumor selective targeting by branched peptides 202
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 200
Binding of HIV-1 gp120 to the nicotinic receptor 200
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 199
Molecular basis of branched peptides resistance to enzyme proteolysis 199
Synthetic peptides of rubella E1 glycoprotein for serological assays 198
NMR studies of lysozyme surface accessibility by using different paramagnetic relaxation probes 198
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 197
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 196
Three-dimensional computation of atom depth in complex molecular structures 196
Totale 25.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021274 0 0 0 0 0 0 0 0 0 0 0 274
2021/20222.237 155 264 150 228 131 82 109 110 97 245 203 463
2022/20233.162 185 322 408 440 340 602 61 254 240 142 124 44
2023/20242.366 79 76 235 117 101 682 817 50 9 43 17 140
2024/20254.699 96 225 524 268 569 262 169 303 366 170 530 1.217
2025/202611.097 858 1.591 1.511 1.410 2.280 448 1.136 399 430 581 282 171
Totale 36.391